Where does Itrace Biomedical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Itrace Biomedical Inc. ranks #47,872 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Itrace Biomedical Inc. hold?

Itrace Biomedical Inc. holds 5 US utility patents granted between 2016 and 2019, spanning 6 technology areas.

What is Itrace Biomedical Inc.'s Innovation Score?

Itrace Biomedical Inc. has an Innovation Score of 29.0 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Itrace Biomedical Inc.'s patent grant rate increasing or decreasing?

Itrace Biomedical Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Itrace Biomedical Inc.'s patents?

Itrace Biomedical Inc.'s patents average 23.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Itrace Biomedical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Itrace Biomedical Inc.

Q: What technology areas does Itrace Biomedical Inc. focus on?

Itrace Biomedical Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 4 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Itrace ranks #47,872 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#47,872
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (29.0/100): 23.6
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47872 · US Corporation #47,872 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,872/49,997
PHOTO-FINISH Isra Surface Vision
CPC-NARROW A61M · 6 areas
INNOV-THIN 29.0/100
CLAIMS-DENSE 23.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Isra Surface Vision GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Itrace Biomedical · this assignee

29
3D Lighting… · lowest

7

What this shows Itrace's Innovation Score is 29.0/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Itrace's grants concentrate

Itrace Biomedical Inc. is a focused PatentsView assignee: 6 CPC subclasses with 80% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2016. By volume, Itrace sits between Isra Surface Vision GMBH and Iveco Defence Vehicles S.P.A..

Isra Surface Visi…

5
ITI Scotland—Scot…

5
ITO

5
ITP Next Generati…

5
Ittiam Systems PTE

5
ITW

5
Ivax Internationa…

5
Iveco Defence Veh…

5
Itrace Biomedical ◀

5

What this shows Itrace holds 5 patents at rank #47,736, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Itrace

By rank, the assignees closest to #47,736 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Itrace's primary technology class.

Itrace's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Itrace Biomedical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2017	2	40.0%
2018	1	20.0%
2019	1	20.0%

Which technologies does Itrace Biomedical Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61B - DIAGNOSIS; SURGERY; Identification 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#47,872

of 49,997 tracked assignees

Innovation Score

29.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Itrace Biomedical Inc.'s patent record in context - here's where to go next.

Itrace Biomedical Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 80% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #47,872 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Itrace Biomedical Inc. against Isra Surface Vision GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.